Found: 154
Select item for more details and to access through your institution.
MYD88<sup>L265P</sup> and MYD88<sup>other</sup> variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 8483, doi. 10.1007/s00432-023-04714-1
- By:
- Publication type:
- Article
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
- By:
- Publication type:
- Article
Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 6, p. 569, doi. 10.1093/jjco/hyv036
- By:
- Publication type:
- Article
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-019-0834-2
- By:
- Publication type:
- Article
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0695-0
- By:
- Publication type:
- Article
Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
MUC16: The Novel Target for Tumor Therapy.
- Published in:
- Chinese Journal of Lung Cancer, 2022, v. 25, n. 7, p. 452, doi. 10.3779/j.issn.1009-3419.2022.101.31
- By:
- Publication type:
- Article
Response of Lung Adenocarcinoma Harbouring Sensitizing EGFR Mutation to the Fourth-line Combination Treatment of Pembrolizumab and Anlotinib.
- Published in:
- Chinese Journal of Lung Cancer, 2021, v. 24, n. 10, p. 739, doi. 10.3779/j.issn.1009-3419.2021.102.25
- By:
- Publication type:
- Article
Advances in Drug Resistance Mechanisms and Prognostic Markers of Targeted Therapy in ALK-positive Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2020, v. 23, n. 11, p. 1014, doi. 10.3779/j.issn.1009-3419.2020.101.44
- By:
- Publication type:
- Article
China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version).
- Published in:
- Chinese Journal of Lung Cancer, 2018, v. 21, n. 2, p. 67, doi. 10.3779/j.issn.1009-3419.2018.02.01
- By:
- Publication type:
- Article
China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version).
- Published in:
- Chinese Journal of Lung Cancer, 2016, v. 19, n. 7, p. 489, doi. 10.3779/j.issn.1009-3419.2016.07.12
- By:
- Publication type:
- Article
Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases.
- Published in:
- Chinese Journal of Lung Cancer, 2015, v. 18, n. 9, p. 554, doi. 10.3779/j.issn.1009-3419.2015.09.05
- By:
- Publication type:
- Article
Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation in Advanced Lung Adenocarcinoma.
- Published in:
- Chinese Journal of Lung Cancer, 2014, v. 17, n. 5, p. 401, doi. 10.3779/j.issn.1009-3419.2014.05.06
- By:
- Publication type:
- Article
Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 10, p. 529, doi. 10.3779/j.issn.1009-3419.2013.10.06
- By:
- Publication type:
- Article
Treatment Choice for Advanced Non-small Cell Lung Cancer Patients Who Had Gradual Progression After EGFR-TKIs: 32 Cases Report.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 10, p. 524, doi. 10.3779/j.issn.1009-3419.2013.10.05
- By:
- Publication type:
- Article
Efficacy and Safety of Albumin-bound Paclitaxel in Treating Recurrent Advanced Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 10, p. 519, doi. 10.3779/j.issn.1009-3419.2013.10.04
- By:
- Publication type:
- Article
Local Treatment Combined with EGFR-TKIs for Advanced Non-small Cell Lung Cancer with Solitary Progression during EGFR-TKI Treatment.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 10, p. 514, doi. 10.3779/j.issn.1009-3419.2013.10.03
- By:
- Publication type:
- Article
Progressive Patterns of Gifitinib Treating Advanced Non-small Cell Lung Cancer after Obtained Resistance.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 10, p. 510, doi. 10.3779/j.issn.1009-3419.2013.10.02
- By:
- Publication type:
- Article
A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage Treatment in Refractory or Relapsed Small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 9, p. 470, doi. 10.3779/j.issn.1009-3419.2013.09.06
- By:
- Publication type:
- Article
Chinese Guidelines on the Diagnosis and Treatment of Primary Lung Cancer (2011 Version).
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 12, p. 677, doi. 10.3779/j.issn.1009-3419.2012.12.01
- By:
- Publication type:
- Article
Efficacy of Pemetrexed as Second-line Therapy or Beyond in Patients with Advanced Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 3, p. 179, doi. 10.3779/j.issn.1009-3419.2012.03.08
- By:
- Publication type:
- Article
Reply to ”A promoter polymorphism in the CASP8 gene is not associated with cancer risk”.
- Published in:
- 2008
- By:
- Publication type:
- Letter
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.
- Published in:
- Nature Genetics, 2007, v. 39, n. 5, p. 605, doi. 10.1038/ng2030
- By:
- Publication type:
- Article
Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer.
- Published in:
- BMC Immunology, 2018, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12865-018-0249-9
- By:
- Publication type:
- Article
The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 5, p. e202, doi. 10.1111/ajco.13831
- By:
- Publication type:
- Article
A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 5, p. e486, doi. 10.1111/ajco.13770
- By:
- Publication type:
- Article
Dismal outcome of relapsed or primary refractory adult T‐cell lymphoblastic lymphoma: A retrospective study from China.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 2, p. e87, doi. 10.1111/ajco.13562
- By:
- Publication type:
- Article
A prognostic nomogram constructed for relapsed or refractory diffuse large B‐cell lymphoma patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 2, p. e11, doi. 10.1111/ajco.13222
- By:
- Publication type:
- Article
Long‐term survival and prognostic analysis of advanced stage follicular lymphoma in the rituximab era: A China single‐center retrospective study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 3, p. 289, doi. 10.1111/ajco.13463
- By:
- Publication type:
- Article
R‐CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B‐cell lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 6, p. 385, doi. 10.1111/ajco.13396
- By:
- Publication type:
- Article
Clinicopathologic characteristics and outcome of patients with different EGFR mutations.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 3, p. 166, doi. 10.1111/ajco.13072
- By:
- Publication type:
- Article
Clinical response to apatinib monotherapy in advanced non-small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 3, p. 264, doi. 10.1111/ajco.12834
- By:
- Publication type:
- Article
Efficacy of icotinib in lung squamous-cell cancer: A real-world experience from single institution.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 6, p. 379, doi. 10.1111/ajco.12669
- By:
- Publication type:
- Article
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e423, doi. 10.1111/ajco.12610
- By:
- Publication type:
- Article
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version).
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 1, p. 87, doi. 10.1111/ajco.12608
- By:
- Publication type:
- Article
Quality publishing.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers.
- Published in:
- Analytical & Bioanalytical Chemistry, 2015, v. 407, n. 17, p. 5065, doi. 10.1007/s00216-015-8484-x
- By:
- Publication type:
- Article
Development and validation of a UPLC-MS/MS assay for the quantification of simotinib in human plasma.
- Published in:
- Analytical & Bioanalytical Chemistry, 2014, v. 406, n. 6, p. 1799, doi. 10.1007/s00216-013-7570-1
- By:
- Publication type:
- Article
Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer: A systematic review and meta-analysis.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 4, p. 831, doi. 10.1007/s10637-022-01242-6
- By:
- Publication type:
- Article
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center study.
- Published in:
- Journal of Clinical Apheresis, 2012, v. 27, n. 2, p. 64, doi. 10.1002/jca.21204
- By:
- Publication type:
- Article
Prognostic impact of mutation profiling in patients with stage II and III colon cancer.
- Published in:
- Scientific Reports, 2016, p. 24310, doi. 10.1038/srep24310
- By:
- Publication type:
- Article
The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 753, doi. 10.4143/crt.2021.905
- By:
- Publication type:
- Article
Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920953738
- By:
- Publication type:
- Article
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142500
- By:
- Publication type:
- Article
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0143515
- By:
- Publication type:
- Article
A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091388
- By:
- Publication type:
- Article
Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0089848
- By:
- Publication type:
- Article
The Molecular Detection and Clinical Significance of <i>ALK</i> Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084501
- By:
- Publication type:
- Article